Detection of peptide-specific cytotoxic T-lymphocyte precursors used for specific immunotherapy of pancreatic cancer.
- 18 December 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 98 (1) , 45-50
- https://doi.org/10.1002/ijc.10145
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Expression of Tumor-rejection Antigens in Gynecologic CancersJapanese Journal of Cancer Research, 2000
- Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypesInternational Journal of Cancer, 2000
- Identification of a Gene Coding for a New Squamous Cell Carcinoma Antigen Recognized by the CTLThe Journal of Immunology, 2000
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaNature Medicine, 1998
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 1998
- IFN-γ gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancerGene Therapy, 1997
- A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.The Journal of Experimental Medicine, 1996
- Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.The Journal of Experimental Medicine, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991